Modelling of ciprofloxacin killing enhanced by hyperbaric oxygen treatment in Pseudomonas aeruginosa PAO1 biofilms
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“targeting the low oxygen tension by exposure of biofilms to hyperbaric oxygen therapy (HBOT) improves the anti-biofilm effect of quinolones (Kolpen et al., 2017; Gade et al., 2018).”
From Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents—How P. aeruginosa Can Escape Antibiotics (2019) · cites this paper as Gade et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Bjarnsholt, T., Alhede, M., Alhede, M., Eickhardt-Sørensen, S. R., Moser, C., Kühl, M., Jensen, P. Ø., & Høiby, N. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.06.002 · Cited by 764 · cited 1×
“The biofilms in CF lungs are, however, not adhered to solid surfaces, but are embedded as small aggregates in the viscous endobronchial mucus [21].”
BackgroundSelf-citationStewart, P. S., Zhang, T., Xu, R., Pitts, B., Walters, M. C., Roe, F., Kikhney, J., & Moter, A. (2016) · npj Biofilms and Microbiomes · doi:10.1038/npjbiofilms.2016.12 · Cited by 157
Grillon, A., Schramm, F., Kleinberg, M., & Jehl, F. (2016) · PLOS ONE · doi:10.1371/journal.pone.0156690 · Cited by 124
Research works printed but not linked: 38
- M Jacobs, 2016, Distinguishing Antimicrobial Models with Different Resistance Mechanisms via Population Pharmacodynamic Modeling, PLoS Comput Biol, 12, e1004782, 10.1371/journal.pcbi.1004782 · DOI
- M Kolpen, 2017, Hyperbaric oxygen sensitizes anoxic Pseudomonas aeruginosa biofilm to ciprofloxacin, Antimicrobial Agents and Chemotherapy, 61, AAC.01024
- M Kolpen, 2016, Reinforcement of the bactericidal effect of ciprofloxacin on Pseudomonas aeruginosa biofilm by hyperbaric oxygen treatment, International Journal of Antimicrobial Agents, 47, 163, 10.1016/j.ijantimicag.2015.12.005 · DOI
- S Kiesewetter, 1993, A mutation in CFTR produces different phenotypes depending on chromosomal background, Nature genetics, 5, 274, 10.1038/ng1193-274 · DOI · Paper page
- MJ Hoegger, 2014, Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis, Science, 345, 818, 10.1126/science.1255825 · DOI · Paper page
- R Boucher, 2004, New concepts of the pathogenesis of cystic fibrosis lung disease, European Respiratory Journal, 23, 146, 10.1183/09031936.03.00057003 · DOI · Paper page
- JC Davies, 2007, Clinical review: Cystic fibrosis, BMJ: British Medical Journal, 335, 1255, 10.1136/bmj.39391.713229.AD · DOI · Paper page
- N Høiby, 2010, Pseudomonas aeruginosa biofilms in cystic fibrosis, Future microbiology, 5, 1663, 10.2217/fmb.10.125 · DOI · Paper page
- T Bjarnsholt, 2009, Pseudomonas aeruginosa Biofilms in the Respiratory Tract of Cystic Fibrosis Patients, Pediatric Pulmonology, 44, 547, 10.1002/ppul.21011 · DOI · Paper page
- D Worlitzsch, 2002, Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients, Journal of Clinical Investigation, 109, 317, 10.1172/JCI0213870 · DOI · Paper page
- M Kolpen, 2014, Nitrous Oxide Production in Sputum from Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Lung Infection, Plos One, 9, e84353, 10.1371/journal.pone.0084353 · DOI · Paper page
- ES Cowley, 2015, Pediatric Cystic Fibrosis Sputum Can Be Chemically Dynamic, Anoxic, and Extremely Reduced Due to Hydrogen Sulfide Formation, Mbio, 6, e00767-15, 10.1128/mBio.00767-15 · DOI · Paper page
- M Kolpen, 2010, Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis, Thorax, 65, 57, 10.1136/thx.2009.114512 · DOI · Paper page
- M Kolpen, 2014, Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen, Clinical and Experimental Immunology, 177, 310, 10.1111/cei.12318 · DOI · Paper page
- C Moser, 2017, Biofilms and host response—helpful or harmful, Apmis, 125, 320, 10.1111/apm.12674 · DOI · Paper page
- PØ Jensen, 2017, Microenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response, Apmis, 125, 276, 10.1111/apm.12668 · DOI · Paper page
- KN Kragh, 2014, Polymorphonuclear Leukocytes Restrict Growth of Pseudomonas aeruginosa in the Lungs of Cystic Fibrosis Patients, Infection and Immunity, 82, 4477, 10.1128/IAI.01969-14 · DOI · Paper page
- MC Walters, 2003, Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin, Antimicrobial Agents and Chemotherapy, 47, 317, 10.1128/AAC.47.1.317-323.2003 · DOI · Paper page
- MA Lobritz, 2015, Antibiotic efficacy is linked to bacterial cellular respiration, Proceedings of the National Academy of Sciences of the United States of America, 112, 8173, 10.1073/pnas.1509743112 · DOI · Paper page
- H Arai, 2014, Enzymatic Characterization and In Vivo Function of Five Terminal Oxidases in Pseudomonas aeruginosa, Journal of Bacteriology, 196, 4206, 10.1128/JB.02176-14 · DOI · Paper page
- HD Williams, 2006, Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa, Advances in microbial physiology, 52, 1, 10.1016/S0065-2911(06)52001-6 · DOI · Paper page
- L Line, 2014, Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum, Frontiers in Microbiology, 5, 554, 10.3389/fmicb.2014.00554 · DOI
- L Fernández-Barat, 2017, Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment, Journal of Cystic Fibrosis, 16, 222, 10.1016/j.jcf.2016.08.005 · DOI · Paper page
- JF Chmiel, 2014, Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections, Annals of the American Thoracic Society, 11, 1120, 10.1513/AnnalsATS.201402-050AS · DOI · Paper page
- DJ Dwyer, 2015, Unraveling the physiological complexities of antibiotic lethality, Annual review of pharmacology and toxicology, 55, 313, 10.1146/annurev-pharmtox-010814-124712 · DOI · Paper page
- B Cao, 2016, Diffusion Retardation by Binding of Tobramycin in an Alginate Biofilm Model, PLoS ONE, 11, e0153616, 10.1371/journal.pone.0153616 · DOI · Paper page
- N Grégoire, 2010, Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa, Antimicrobial agents and chemotherapy, 54, 2379, 10.1128/AAC.01478-08 · doi:10.1128/aac.01478-08
- P Stewart, 1996, Theoretical aspects of antibiotic diffusion into microbial biofilms, Antimicrobial Agents and Chemotherapy, 40, 2517, 10.1128/AAC.40.11.2517 · DOI · Paper page
- VH Tam, 2005, Modelling time-kill studies to discern the pharmacodynamics of meropenem, Journal of Antimicrobial Chemotherapy, 55, 699, 10.1093/jac/dki086 · DOI
- C Stover, 2000, Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen, Nature, 406, 959, 10.1038/35023079 · DOI · Paper page
- PS Stewart, 1994, Biofilm accumulation model that predicts antibiotic resistance of Pseudomonas aeruginosa biofilms, Antimicrobial Agents and Chemotherapy, 38, 1052, 10.1128/AAC.38.5.1052 · DOI
- A Cunningham, 1995, Evaluation of a coupled mass transport-biofilm process model using dissolved oxygen microsensors, Water Science and Technology, 32, 107, 10.2166/wst.1995.0274 · doi:10.2166/wst.1995.0274
- ME Roberts, 2004, Modeling antibiotic tolerance in biofilms by accounting for nutrient limitation, Antimicrobial Agents and Chemotherapy, 48, 48, 10.1128/AAC.48.1.48-52.2004 · DOI · Paper page
- RM Corless, 1996, On the LambertW function, Advances in Computational mathematics, 5, 329, 10.1007/BF02124750 · DOI · Paper page
- H Arai, 2011, Regulation and function of versatile aerobic and anaerobic respiratory metabolism in Pseudomonas aeruginosa, Frontiers in microbiology, 2, 10.3389/fmicb.2011.00103 · DOI · Paper page
- R Skeel, 1990, A Method for the Spatial Discretization of Parabolic Equations in one Space Variable, SIAM Journal on Scientific and Statistical Computing, 11, 1, 10.1137/0911001 · doi:10.1137/0911001
- P Han, 1996, Temperature Dependence of Oxygen Diffusion in H2O and D2O, Journal of Physical Chemistry, 100, 5597, 10.1021/jp952903y · DOI · Paper page
- P Suci, 1994, Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms, Antimicrobial agents and chemotherapy, 38, 2125, 10.1128/AAC.38.9.2125 · DOI · Paper page
Cited by
Ciofu, O., & Tolker-Nielsen, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00913 · Cited by 842
Biofilm and wound healing: from bench to bedside
Goswami, A. G., Basu, S., Banerjee, T., & Shukla, V. K. (2023) · European Journal of Medical Research · doi:10.1186/s40001-023-01121-7 · Cited by 178
Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms
Fernández-Billón, M., Llambías-Cabot, A. E., Jordana-Lluch, E., Oliver, A., & Macià, M. D. (2023) · Biofilm · doi:10.1016/j.bioflm.2023.100129 · Cited by 170
Metadata
- Authors
- Gade, P. A. V., Olsen, T. B., Jensen, P. Ø., Kolpen, M., Høiby, N., Henneberg, K.-Å., & Sams, T.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-06-14
- Volume
- 13
- Issue
- 6
- Pages
- e0198909
- ISSN
- 1932-6203
- Cited by
- 22
- References
- 4
- Language
- en
- Funders
- University of Copenhagen, Center for Antimicrobial Research, UC-CARE, http://uc-care.ku.dk (50061804231-F16)
- Danish Council for Independent Research, Technology and Production Sciences, FTP, http://dff.ufm.dk (DFF–4184-00515)
- Cystic Fibrosis Foundation, USA, http://www.cff.org (HOIBY05A0)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.